252 related articles for article (PubMed ID: 29252122)
1. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation.
Hoodin F; LaLonde L; Errickson J; Votruba K; Kentor R; Gatza E; Reddy P; Choi SW
Biol Blood Marrow Transplant; 2019 Feb; 25(2):343-353. PubMed ID: 30244099
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant.
Syrjala KL; Dikmen S; Langer SL; Roth-Roemer S; Abrams JR
Blood; 2004 Nov; 104(10):3386-92. PubMed ID: 15251983
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.
Scherwath A; Schirmer L; Kruse M; Ernst G; Eder M; Dinkel A; Kunze S; Balck F; Bornhäuser M; Ehninger G; Dolan K; Gramatzki M; Kolb HJ; Heußner P; Wilhelm H; Beelen DW; Schulz-Kindermann F; Zander AR; Koch U; Mehnert A
Psychooncology; 2013 Jul; 22(7):1509-16. PubMed ID: 22945857
[TBL] [Abstract][Full Text] [Related]
6. The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients.
Hoogland AI; Nelson AM; Small BJ; Hyland KA; Gonzalez BD; Booth-Jones M; Anasetti C; Jacobsen PB; Jim HSL
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1974-1979. PubMed ID: 28797784
[TBL] [Abstract][Full Text] [Related]
7. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.
Syrjala KL; Artherholt SB; Kurland BF; Langer SL; Roth-Roemer S; Elrod JB; Dikmen S
J Clin Oncol; 2011 Jun; 29(17):2397-404. PubMed ID: 21537032
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study.
Wauben B; van der Poel MWM; Greevenbroek MMJ; van Yperen NC; Schram MT; van Boxtel MPJ; Sastry M; Simons SO; Stehouwer CDA; Dagnelie PC; Wesselius A; Schouten HC; Köhler S
Transplant Cell Ther; 2023 Jul; 29(7):468.e1-468.e8. PubMed ID: 36966872
[TBL] [Abstract][Full Text] [Related]
9. Real-World Economic Burden Associated with Transplantation-Related Complications.
Perales MA; Bonafede M; Cai Q; Garfin PM; McMorrow D; Josephson NC; Richhariya A
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1788-1794. PubMed ID: 28688917
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.
Mayo SJ; Messner HA; Rourke SB; Howell D; Victor JC; Lipton JH; Kuruvilla J; Gutpa V; Kim DDH; Michelis FV; Metcalfe K
Bone Marrow Transplant; 2020 May; 55(5):918-928. PubMed ID: 31745248
[TBL] [Abstract][Full Text] [Related]
11. Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
Bonafede M; Richhariya A; Cai Q; Josephson NC; McMorrow D; Garfin PM; Perales MA
J Med Econ; 2017 Dec; 20(12):1244-1251. PubMed ID: 28782449
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study.
Zhou J; Han J; Nutescu EA; Patel PR; Sweiss K; Calip GS
Pharmacotherapy; 2019 Jan; 39(1):55-66. PubMed ID: 30485471
[TBL] [Abstract][Full Text] [Related]
13. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.
Munshi L; Darmon M; Soares M; Pickkers P; Bauer P; Meert AP; Martin-Loeches I; Staudinger T; Pene F; Antonelli M; Barratt-Due A; Demoule A; Metaxa V; Lemiale V; Taccone F; Mokart D; Azoulay E; Mehta S;
Transplant Cell Ther; 2021 Jan; 27(1):78.e1-78.e6. PubMed ID: 33011289
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
[TBL] [Abstract][Full Text] [Related]
15. Is age a risk factor for cognitive changes following hematopoietic cell transplantation?
Stratton J; Sylvia A; Hoodin F; Choi SW; Pawarode A; Giordani B; Votruba K
Bone Marrow Transplant; 2021 Mar; 56(3):567-569. PubMed ID: 32862198
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail Recipients.
Pamukcuoglu M; Bhatia S; Weisdorf DJ; DeFor TE; Ustun C; Nayar M; Holtan SG; Jurdi NE; Thyagarajan B; Brunstein CG; Bachanova V; Warlick ED; Severseike B; Te HS; Lund T; Arora M
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2454-2460. PubMed ID: 31394273
[TBL] [Abstract][Full Text] [Related]
17. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
18. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
19. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
Jones D; Vichaya EG; Wang XS; Sailors MH; Cleeland CS; Wefel JS
Cancer; 2013 Dec; 119(23):4188-95. PubMed ID: 24105672
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
